Clinical trial
Development of Novel Assays to Evaluate and Measure Circulating Cancer Biomarkers
NCT02874729 is registered in ClinicalTrials.gov with King's College London as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Development of Novel Assays to Evaluate and Measure Circulating Cancer Biomarkers
- Lead sponsor
- King's College London
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- November 30, 2016
- Completion date
- Not reported
- Enrollment
- 400 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
tumors